← Eichor
Study identifier: NCT07141056 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study

Condition: HCC - Hepatocellular Carcinoma · Psychological Distress · Immune Checkpoint Inhibitors (ICIs)  ·  Sponsor: Guilin Medical University, China

PhaseN/A
Planned participants700
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn if emotional distress affects how well liver cancer treatment works in people receiving immunotherapy. Emotional distress means feeling anxious or depressed. The study aims to answer whether having emotional distress before treatment or changes in emotional distress during treatment affect how well immunotherapy works to treat liver cancer. Researchers will compare participants with and without emotional distress to examine differences in how long the cancer stays under control, treatment response, and overall survival time. Study participants will complete mood and quality of life questionnaires, meet with mental health specialists for emotional assessments, undergo regular blood tests to measure stress hormones, have routine medical check-ups and scans to monitor their cancer status, and be followed for up to 3 years. The study includes three groups of people with liver cancer: those starting immunotherapy for cancer that cannot be removed by surgery, those receiving immunotherapy after surgery, and those receiving immunotherapy before surgery. To be eligible for participation, individuals must be 18 years or older, diagnosed with liver cancer, about to start immunotherapy treatment, and able to complete mood questionnaires.

This description comes directly from the study's public registry record.

Talk to the study team

Yu Yaqun, MD. PhD  ·  + 86 18172681387  ·  yyq0129@glmc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (5)

The Second Affiliated Hospital of Guangdong Medical UniversityZhanjiang, Guangdong, ChinaRecruiting
The Affiliated Hospital of Guilin Medical UniversityGuilin, Guangxi, ChinaRecruiting
The Second Affiliated Hospital of Guilin Medical UniversityGuilin, Guangxi, ChinaRecruiting
Shaoyang Central HospitalShaoyang, Hunan, ChinaRecruiting
The First Affiliated Hospital of Shaoyang CollegeShaoyang, Hunan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07141056